Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001549 · ClinicalTrials.gov registry record

Diagnosis and Natural History Study of Patients With Neurological Conditions

A clinical trial of Dementia and Parkinson's Disease, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
600
Enrollment target
1
Study location

NCT00001549: Completed study of Dementia and Parkinson's Disease, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00001549 is a study of Dementia and Parkinson's Disease that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 600 participants, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001549, a study of Dementia and Parkinson's Disease, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
600 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to improve understanding of neurological conditions. Patients participating in this study will continue receiving medical care, routine laboratory tests, and diagnostics tests (X-rays, CT-scans, and nuclear imaging), from their primary care physician. Doctors at the NIH plan to follow these patients and offer advice and assistance to their primary care physicians.

Study Locations (1)

Maryland

  • National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 1995-10
Est. Completion 2006-01

What the finished NCT00001549 record still lists

NCT00001549 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (92% lower).

The record links to 5 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.

NCT00001549 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00001549 about?

NCT00001549 is a clinical study titled "Diagnosis and Natural History Study of Patients With Neurological Conditions". The purpose of this study is to improve understanding of neurological conditions. Patients participating in this study will continue receiving medical care, routine laboratory tests, and diagnostics tests (X-rays, CT-scans, and nuclear imaging), from their primary care physician. Doctors at the NIH ...

What is the current status of trial NCT00001549?

This trial is currently completed. The enrollment target is 600 participants. The study started on 1995-10. Estimated completion is 2006-01.

What conditions does trial NCT00001549 study?

This clinical trial studies the following conditions: Dementia, Parkinson's Disease, Alzheimers Disease, Multiple System Atrophy, Movement Disorder.

Who is sponsoring clinical trial NCT00001549?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001549 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00001549's enrollment target sits among peer trials

600 43rd of 199 higher than 156 of 199 other Dementia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00001549, the US trial registry maintained by the National Library of Medicine. NCT00001549 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.